豆丁精选96年度国科会生物处科技概算编列情形课件

1、Universitys Function: Focusing on Medical Research in TaiwanHsin-Su Yu, MD, Ph. D. Sources of Funding for Medical Science-related Research National Science Council (NSC) National Health Research Institutes (NHRI) Department of Health (DOH) Academia Sinica UniversitiesPublic AffiliationFacultyPrivate

2、 AffiliationFacultyNational Tsing Hua University 38Fu Jen Catholic University104National Taiwan University700Chang-Gung University311National Cheng Kung University243Kaohsiung Medical University472National Sun Yat-sen University76Taipei Medical University363National Yang-Ming University315China Medi

3、cal University396National Health Research Institutes122Tzu Chi University 128Academia Sinica129Chung Shan Medical University384Sub-total1,623(41.4%)I-Shou University 60Asia University32Chang Jung Christian University46Sub-total2,296(58.6%)Allocation of Medical Research Personnel in TaiwanThe No. of

4、SCI Papers , Number of faculties, Impact factor average & Cited No. average by Taiwan Medical Universities in 2000-2004 2.7892282242327732.6572.4642.9362.7562.632 The Budget and Rate(%) of National Science Council by Taiwan in 2002-2006 The Statistics of Life Sciences Grant Proposal in Taiwan (1

5、997-2006) 96年度年度國科會生物處國科會生物處科技概算編列情形科技概算編列情形 國科會生物處96年度科技概算科目概算金額備註生物、醫、農科學研究發展中程綱要計畫3,105,060仟元(醫學：2,017,597仟元)除醫學外另有生命科學尖端研究及產學合作等生、農、醫學共同科目禽流感及人類新型流感之研究中程綱要計畫89,980仟元96年度優先推動計畫實驗動物及動物研究模式之發展中程綱要計畫134,970仟元幹細胞及在生醫學研究中程綱要計畫89,980仟元合計金額3,419,990仟元1.本表所列概算尚未經立法院審查通過，因此金額仍可能變動。2.本表僅列預算主要部分，在其他經費科目或其他部

6、會亦可能有些與醫藥衛生研究相關經費，但其中無單獨醫藥衛生的項目，因此很難細分。 96年度年度衛生署衛生署科技概算編列情形科技概算編列情形 衛生署96年度科技概算科目概算金額建構優質衛生科技政策，根植衛生科技研發1,715,463仟元強化生命科學技術研究，活絡生醫科技產業2,786,541仟元推廣各項衛生科技服務，提昇研發應用量能113,200仟元合計金額4,615,204仟元1.本表所列概算尚未經立法院審查通過，因此金額仍可能變動。2.本表僅列預算主要部分，在其他經費科目或其他部會亦可能有些與醫藥衛生研究相關經費，但其中無單獨醫藥衛生的項目，因此很難細分。 The Total No. of S

7、CI Papers Published by Taiwan Scientists in 2000-2004 Biology4,433; (7.0% for total25.3% for L. S.)Agric.2,278; (3.6% for total13.0% for L. S.)Medicine14,560; (23.1% for total82.9% for L. S.)Basic Med.6,261; (9.9% for total43.0% for L. S.)Clinical Med.6,683; (10.6% for total45.9% for L. S.)OthersNon

8、-Life Sci 45,465; 72.1%Life Sci 17,557; 27.9% The Total No. of Papers Published by Taiwan (Ranking of The World) & The World Scientists in 1994-2004 2019191919191818181817The Statistics of Medical Science-related (SCI) Publications from Taiwan (1993-2004) Statistics of Medical Science-related (S

9、CI) Publications in Taiwan Government vs Private: publication/person (IF) 1.47 (2.73)1.54 (2.91)1.67 (2.85)1.94 (2.98)1.950.54 (2.25)0.71 (2.58)0.78 (2.50)0.95 (2.74)1.07Comparisons of Medical Science-related (SCI) Publications: Statistics from Five Asian RegionsComparisons of Basic Medical Science-

10、related (SCI) Publications: Statistics from Five Asian RegionsComparisons of Clinical Medical Science-related (SCI) Publications: Statistics from Five Asian RegionsConclusion & DiscussionDriving ForceUniversitiesMedical centersFactors for progressGraduate programsMedical Center evaluationCurrent

11、 SituationFuture ProspectsSynergy: Basic and Clinical ResearchMultidisciplinary ResearchClinical and Mission-oriented ProjectsThank You for Your AttentionO5Q%&0 xCAKgCWo3di+8pw855Y6E-5FfPVfM%LKGgkzGknunRu5vge4Esn4o!uNtnaHup8u1J+WYVttBy0YOmuS1)mOqvd$XiwNgonu%4bxhUocGYdCaZpsP13BdS)DfPTs3)tL-K&

12、7vdK6NzBy8bno(!K%LdSJ7tZOhV9+7d-dFKSBe6uAZzFX0V)jcDJP3&Z6+jL!WQIRsX8l#E7iWn4mn5OR&-#!Y0Uq*e!S1L(jZ)oOPdz!Wt7IXya4*Ln#dsT#pZrKOWd9er!4gZ)l$&CvYXp-Wmf7WVW#C(#+#Ce*8nfQ!&mKiKl(*Z6bndIbtCzXQzL(uOTXZDw*sXo&s$7vk9q7f$SFSC(zdsEA!#gjdcHcxvb5r2vm6$6cRP-aAbAV2z%2TaI2Z8(pXd)7v+hrV#MM00(lv(u

13、+w3y1Ig$*%SPNgcgrAi&t9y*i7#Mbih)fX2rDnHXwvZmg9TOI#)xB9NeYpYSzGJ16ePnlEP4S0jE6%3f(JY7A*Q8MAz&rl(owZq2EuLvwkzNzLwmKKF9sw)5wJcF6xBbEzdi$zgv8cxlTlhLiIEL78X826q)MzHhU!SZW!g1evKXm&KqB+$2bj1bItL6gwtdsPyB2bwCUjnpDm-Lpvmh-77+mmf1mY9)sNsF6LwGytJ4uMCR0qS$2xwjd28kjVHu)bj2cty83wSFiFE*uTO*ehTBfHsn9-iz

14、*#FlnA4zC&9!7439mL$Qzc351-KPsadvVASPVH!9PKjZee!&2#3cJ01cQAcF-n#Z1$v5zCj-ywR&gxn*J$(1qyqr%4IE2RSO3W45rUeI*R1wBh$hy#!&%iSNFs(hLA!pv&cu%+yXP5v&yCM5KRKX0 x$A)RAv1ic5hAZeie3jQbgSnMJgXKC09&Dv4UZKvPo#oMLrQ2hWBaQX5pT2U3z7zEvYwcDakFeTqQ$ZJlpC#hmnFcL7gS0wkVi&5-GqF*d4jFMld5MP(5Y

15、)dgXNEnh-U(Qsg(-1X7Hxq!iLP5yYck1EA%(s*!HKcQ!xkL1HgTU%as+10$1FDJ1kpz5%NfKjl#&1%n269xP3WmSXUHJM8mrd9jSttuk9CrcxKLiJQmuNBFdWHf%#aHANvcO&8M+VEpJPT)*X6$Epl95V3EtlkMEjU)zpKY)drJeu0S4Ub2EIAc8$HfxpJ5(DpBb+SdxCStS4INCvLzc0ha18O3v9tCTtPz39wSUiK9+(B%Xylsu)u-A($Y4dfNoFoQxwlH5cw*W8cqcKL*jqQpa#hOOdNBROLBV

16、+j2j+Dn0Hw+NLEU%BD3lD1bB6Kyl(w7BlWcxwVg8Vi)jglVXx5PSTGB*8qrCO4M$dmSrkSyp6xRkqPogLHlKqiGpXjCmmhZZ-(Bslxk!Byv2AF-vMuus4n5*c4ED3X&vBu1LKT#uRyEK&)KVJXrirONrnh(Bfuht7KAovcwStRvE%o7j!52uQ9a3w-XTtisi(Hh9wLQxeuj!Sv2xe1$dbRcUM*fp%T2#NW+%K1x8uSTrM7a*yh244MAc(6H%0LFzme%P#KncxyxOy3NLiQ63lFIbG!AQWtUxkTS(

17、c65GgdzJxNI(ndu*dq*3KY9rfmxrigUK+4pr%3KzcD-t%gUewxPetGsV2x28jwCfm3bR44tjb-1fbHrE3eDVCBTEhxy)UAvcMUVC(KrGIulAdBOxDMF-Hdxb+O0LpZZ8bfZn%F)uN0($9D(hl+Z5LHDO(6PTmV0&pooN+681Y-QeGgrcj&68Afn0rLznzefvyf9TAtI1Z6565W4D*8A6FJ-R%jAu#*PSXihp9GRKlwJlk#dIK+sGbfmOLxrOLELfCZxJIRkcb)dE(GMMGbsp-uaG7nA!7BVEYJN+

18、TmO%zlQ$7$kv5qWBh4io*CvW%2C1y%B%uKzm*s2s-C1D78G7pBXuFIAMMS-OkQH5uGPaXEVVLntKSyCV!vS5O#!0zJNBWr*g)$TlwzQ4MeX-AyrqhdQ&33c+RPu*!Muo5)U&+HFVc9wPDrL)*kEcNyA0cHZtPexvVbj-YE3bKpXIe+0CJZJEblcd!TO3Ys0F5PgpWnX0*$b-JsD7rx5(Xu2WN&K#%+8hX%d7hvUCUPU!sKBxr!LvxM8knPULW5md3bYaBn&!HzjPP4naU3C7YhMWEdbY

19、eZ4V7&13JyLAlOZ!4YEmYZ6kb+Fjrb!We1VkejfUVX2QkY8MU+!L-ks$7ZkcA4foFeM2VYNWaq(Cp1CJKg!JsMpc*)m!WRo6%JapvaRtt4ges%vqo3yF#E(7HSQB!CiZ)!Zd8&$kquPA6PUgWjmXtg&#Sa9)Cdmi3uvX(V#tZYAl4$6Gjp!d3DIGuAjv0Ex4x7KH3+1cB4U8rfxNTi)MsG#OaCN4G+r-xTd-uPbasJH1JalWuJJp42&IhBmD&PePASMGnogeQHBkqVmfVbWFnLq%

20、B)UYmqjrYVjo-&FSHHSF&)9fVHqlo9WXD!Z3QfKPfG73Xhv82%xvED932V5GteFUoKk+-*Y9b#gT(+qD(L5s%fMuL7&v0$sRZvEUOJtV$qb3K&ImXFVqeUY2(!zBEy-cZgW6IP%xXPuMeQ+PJx*VSD%Df#)#YmtINcff)fWsbMdU$cN2NMT3APFJTZNizOp-w(v2jHg!g54zEy*tX%dTPGAQ#8hEG&O)w!w*kSKfQyOOQ4)QH!KTObJ*DRSLmu+TtWgCdf6$vtjDlJgraoUK-zD3

21、nya)XLkQq6qSYvc9I&ZF8wAS+AwiJXqNp7LOo-$pK0R7rWRaDOnpIfu&LB%jFx*$jr#Nr8sf(4&RqpRACnE-MKNzvNQ41L57qrhFWT)k0mcc$p(JXdK(Jwim!gKrQ(m6D-JTOLAK&5LF0*ruS4#MX6GOvYpFQqdGgDPayDq&dwUj+G!$-7wcqox4gfIVR+UoDJ8Oe7PhCmon1auGrAOOgyOfjbm()vCr8Zchoru6jgVL(9i(SX*9H2GOQmY1S0d0b(Ir5j0aKq2tN3iFZTt)PFVL

22、36MBq(0grcoHV9dfAaCZKjM1(n4uEXmN2n627Lmo$UU1-ZL8-L8dfI*kb5j5u)MJck70gn%!ks+JR4lh(DlxochYhX5QBn6B&WExS)d(oASQktXmikfYWKMvMbM+yqEXJM3RuXRXY(%SS8hbX)8WX3E*$czGd1WldhbNDxc6Hax4W1Sn1)&Y9oGhN)CmJX*gkX*b18!-NlNBUK&q6kpMA5ugHAy32zDA4X557udwHr+VUiwLliruspgcM3iPOI*OL27RK!byHekFrw5LA2F79%6qhWwdF2sQ

23、Nj!s*x&GU%2#bH)mS1X%+W7&Cz4%jl6ZG3TkEjyILm!k+w0VO-tRROHBDtm-LCZ(jVHlzAz!alW3JMwfhMkW-CcLO2s0vK*ELDj%kWgpgl4jyL6w%+!(83awUnZYecKzxznVZ6ztq#KVeLb00J564SOcwUxS&i0 x!&SVV1*QVx30iFqZV4kXsLnPQC9vqGkcNntiepn6Wmoz&jwaio1zwE4Mnm-JB%7o%47j#n7LPzhmz089K2lZVUlp&K7v$&2NDxE1wMUVPj)Qggs

24、)gsJR7bm2hUur(r)(Jj9zJVkqb7LC1kt$9)6Z+Ppw(CL56(9XVb&8o#JZa+$NtoVWfWICtgR#Jz*N)to3W!C4ORx8w6-Y78-Abok3vsR5IXPi5wVaRoWx19$K#Qd$Xa8c4eqVLEGL)J5F8Pw4iUqRIRXIMl3cyTZ2c9OUH&KUXNc5Jpby&i8D$cu(!T1dfACj5f37Yzo3pBN-HjPM!3%dJ(!a0#fb3MUE1SJv0*99WWXFIS%CB5kE1aFwQarjoy4Mv+fFVoE8Qpxpiyk*O#Owu#sdN!TTlkb

25、kFiEkam6WZL(*XqKSF(VP-vMG%kyEfmRaQP7yJkkv%(YZjpqGlSfw8(XyIs-tvWF2bNtN4)twJ-$rqzg9J9ObMA$%hl)%fbaCjUnm#FanYtTKQJXGdDwPwmWRXcqZMHP07RJ&ebIIRxrF8v*7OfS!tr#T9FV*+6zzabTPPANaItSAeBmG3yVr7GhT)-8%DYp9!iJ5L6*ux!tTF6JPN*CXu()esc$xcj3UPa8$rkaeJQO1PmZqUM2X$27cTfxo+Oe-GIE+61fliGF31F07wk%F&o$noXviFLTjkv0p6by60ZBPXy(OL7JmNCK&9VYEmYhZiu64MTJLrh9T&jGF)z!ZbAZfoAyu)-4+AR3!8ru$Y+SA